1naresh

Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1nareshArray
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)

Table 2: Procedural details and complications
TIMI 0 TIMI 1 TIMI 2 TIMI 3 Total P Value
No. of patients 110 20 61 114 305 
Ictus to arterial puncture (hr) (mean) 
    Median (IQR) 4.5 ± 2.1 4.5 ± 1.6 4.3 ± 1.6 4.2 ± 1.5 4.4 ± 1.8 NS
4.3 (3.0–5.6) 4.1 (3.3–5.4) 4.4 (3.2–5.7) 4.2 (3.1–5.2) 4.3 (3.1–5.5) 
Ictus to procedure end (hr) (mean) 
    Median (IQR) 6.6 ± 2.1 6.93 ± 2.0 6.3 ± 1.9 5.8 ± 1.6 6.3 ± 1.9 .004
6.5 (5.5–7.8) 7.1 (5.7–8.2) 6.0 (5.0–7.7) 5.8 (4.7–6.9) 6.1 (5.0–7.5) 
No. of passes 
    1 9.1% 25.0% 31.1% 34.2% 23.9% <.001
    2 18.2% 15.0% 16.4% 23.7% 19.7% 
    3 30.0% 15.0% 21.3% 22.8% 24.6% 
    4 13.6% 5.0% 19.7% 11.4% 13.4% 
    >4 29.1% 40% 11.5% 7.9% 18.4% 
Use of adjuvant 40.9% 45.0% 32.8% 36.0% 37.7% NS
Procedure-related clinically significant AE 10.0% 0.0% 6.6% 3.5% 6.2% .09
Symptomatic bleeding events 12.7% 10.0% 8.2% 5.3% 8.9% NS
PH-2 events 9.1% 0.0% 3.2% 3.7% 4.9% NS
Note:—IQR indicates interquartile range; NS, not significant; AE, adverse events.